AI assistant
Sending…
RESMED INC — Director's Dealing 2015
Nov 13, 2015
30071_dirs_2015-11-13_ea715770-5c78-4351-8366-6e3000edb9f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-11
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-11 | ResMed Common Stock | F | 2983 | $58.37 | Disposed | 77404.0894 | Direct |
| 2015-11-11 | ResMed Common Stock | F | 1503 | $58.37 | Disposed | 72901.0894 | Direct |
| 2015-11-11 | ResMed Common Stock | F | 1044 | $58.37 | Disposed | 71857.0894 | Direct |
| 2015-11-11 | ResMed Common Stock | F | 1195 | $58.37 | Disposed | 70662.0894 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/16/2011.
F2: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/15/2012.
F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013.
F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2014.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29